Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com
Published March 13, 2024 · Recall initiated: February 9, 2024
Summary
FDA records drug Class III recall D-0367-2024, published March 13, 2024 and initiated February 9, 2024. Recalling firm: Stason Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 54, 131 bottles; Lot: Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: results slightly under spec at at 9-months.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Stason Pharmaceuticals, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, RxMarch 13, 2024
- FDAFrothy Monkey - Plain Croissant - packaged and sold individuallyMarch 13, 2024
- FDAClindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse PharmaceuticalsMarch 13, 2024
- FDAFrothy Monkey - Chocolate Croissant - packaged and sold individuallyMarch 13, 2024
- FDAClindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: MarlexMarch 13, 2024
- FDASelegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc.September 14, 2016
Questions about this recall
Was Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com recalled?
Yes. FDA published recall D-0367-2024 on March 13, 2024. Reported hazard: Failed Dissolution Specifications: results slightly under spec at at 9-months.
What should I do if I have this product?
Voluntary: Firm initiated · Letter